1326 related articles for article (PubMed ID: 16566899)
41. Is depression associated with dysfunction of the central reward system?
Martin-Soelch C
Biochem Soc Trans; 2009 Feb; 37(Pt 1):313-7. PubMed ID: 19143654
[TBL] [Abstract][Full Text] [Related]
42. Decoding of dopaminergic mesolimbic activity and depressive behavior.
Friedman A; Deri I; Friedman Y; Dremencov E; Goutkin S; Kravchinsky E; Mintz M; Levi D; Overstreet DH; Yadid G
J Mol Neurosci; 2007; 32(1):72-9. PubMed ID: 17873290
[TBL] [Abstract][Full Text] [Related]
43. Transient changes in mesolimbic dopamine and their association with 'reward'.
Wightman RM; Robinson DL
J Neurochem; 2002 Aug; 82(4):721-35. PubMed ID: 12358778
[TBL] [Abstract][Full Text] [Related]
44. Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents.
Shirayama Y; Chaki S
Curr Neuropharmacol; 2006 Oct; 4(4):277-91. PubMed ID: 18654637
[TBL] [Abstract][Full Text] [Related]
45. The rewards of music listening: response and physiological connectivity of the mesolimbic system.
Menon V; Levitin DJ
Neuroimage; 2005 Oct; 28(1):175-84. PubMed ID: 16023376
[TBL] [Abstract][Full Text] [Related]
46. The role of BDNF in depression on the basis of its location in the neural circuitry.
Yu H; Chen ZY
Acta Pharmacol Sin; 2011 Jan; 32(1):3-11. PubMed ID: 21131999
[TBL] [Abstract][Full Text] [Related]
47. Functions of mesolimbic dopamine: changing concepts and shifting paradigms.
Salamone JD
Psychopharmacology (Berl); 2007 Apr; 191(3):389. PubMed ID: 17334798
[No Abstract] [Full Text] [Related]
48. Synaptic plasticity in the mesolimbic system: therapeutic implications for substance abuse.
Chen BT; Hopf FW; Bonci A
Ann N Y Acad Sci; 2010 Feb; 1187():129-39. PubMed ID: 20201850
[TBL] [Abstract][Full Text] [Related]
49. The Role of Dopamine in Inflammation-Associated Depression: Mechanisms and Therapeutic Implications.
Felger JC
Curr Top Behav Neurosci; 2017; 31():199-219. PubMed ID: 27225499
[TBL] [Abstract][Full Text] [Related]
50. Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis.
Carlezon WA; Thomas MJ
Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):122-32. PubMed ID: 18675281
[TBL] [Abstract][Full Text] [Related]
51. The maternal reward system in postpartum depression.
Post C; Leuner B
Arch Womens Ment Health; 2019 Jun; 22(3):417-429. PubMed ID: 30554286
[TBL] [Abstract][Full Text] [Related]
52. Modulation of pain, nociception, and analgesia by the brain reward center.
Mitsi V; Zachariou V
Neuroscience; 2016 Dec; 338():81-92. PubMed ID: 27189881
[TBL] [Abstract][Full Text] [Related]
53. Dopamine-Mediated Major Depressive Disorder in the Neural Circuit of Ventral Tegmental Area-Nucleus Accumbens-Medial Prefrontal Cortex: From Biological Evidence to Computational Models.
Li Y; Zhang B; Pan X; Wang Y; Xu X; Wang R; Liu Z
Front Cell Neurosci; 2022; 16():923039. PubMed ID: 35966208
[TBL] [Abstract][Full Text] [Related]
54. The mysterious motivational functions of mesolimbic dopamine.
Salamone JD; Correa M
Neuron; 2012 Nov; 76(3):470-85. PubMed ID: 23141060
[TBL] [Abstract][Full Text] [Related]
55. Anhedonia and the brain reward circuitry in depression.
Heshmati M; Russo SJ
Curr Behav Neurosci Rep; 2015 Sep; 2(3):146-153. PubMed ID: 26525751
[TBL] [Abstract][Full Text] [Related]
56. Dopamine neurons modulate neural encoding and expression of depression-related behaviour.
Tye KM; Mirzabekov JJ; Warden MR; Ferenczi EA; Tsai HC; Finkelstein J; Kim SY; Adhikari A; Thompson KR; Andalman AS; Gunaydin LA; Witten IB; Deisseroth K
Nature; 2013 Jan; 493(7433):537-541. PubMed ID: 23235822
[TBL] [Abstract][Full Text] [Related]
57. The role of dopamine in reward and pleasure behaviour--review of data from preclinical research.
Bressan RA; Crippa JA
Acta Psychiatr Scand Suppl; 2005; (427):14-21. PubMed ID: 15877719
[TBL] [Abstract][Full Text] [Related]
58. Impact of insulin and insulin resistance on brain dopamine signalling and reward processing - An underexplored mechanism in the pathophysiology of depression?
Gruber J; Hanssen R; Qubad M; Bouzouina A; Schack V; Sochor H; Schiweck C; Aichholzer M; Matura S; Slattery DA; Zopf Y; Borgland SL; Reif A; Thanarajah SE
Neurosci Biobehav Rev; 2023 Jun; 149():105179. PubMed ID: 37059404
[TBL] [Abstract][Full Text] [Related]
59. Dopamine D(3) receptor as a new pharmacological target for the treatment of depression.
Leggio GM; Salomone S; Bucolo C; Platania C; Micale V; Caraci F; Drago F
Eur J Pharmacol; 2013 Nov; 719(1-3):25-33. PubMed ID: 23872400
[TBL] [Abstract][Full Text] [Related]
60. Parallels and Overlap: The Integration of Homeostatic Signals by Mesolimbic Dopamine Neurons.
Hsu TM; McCutcheon JE; Roitman MF
Front Psychiatry; 2018; 9():410. PubMed ID: 30233430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
